Amrize (NYSE:AMRZ) Rating Lowered to “Strong Sell” at Zacks Research

Amrize (NYSE:AMRZGet Free Report) was downgraded by investment analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Wednesday,Zacks.com reports.

AMRZ has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Amrize in a report on Friday, June 26th. Truist Financial reissued a “hold” rating and set a $48.00 target price (down from $65.00) on shares of Amrize in a research note on Tuesday, July 7th. Weiss Ratings upgraded shares of Amrize from a “sell (d+)” rating to a “hold (c)” rating in a report on Thursday, August 13th. Oppenheimer cut their price target on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 21st. Finally, Stephens decreased their price target on Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a report on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $60.57.

Get Our Latest Analysis on AMRZ

Amrize Stock Performance

Amrize stock opened at $44.64 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. The stock has a market cap of $24.69 billion, a PE ratio of 20.57, a P/E/G ratio of 1.07 and a beta of 0.11. Amrize has a 12-month low of $44.30 and a 12-month high of $65.94. The business’s 50-day moving average price is $50.69 and its two-hundred day moving average price is $54.23.

Amrize (NYSE:AMRZGet Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The firm had revenue of $3.50 billion for the quarter. As a group, analysts expect that Amrize will post 2.58 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Baris Oran purchased 3,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was acquired at an average price of $47.38 per share, for a total transaction of $142,140.00. Following the purchase, the chief financial officer owned 3,000 shares of the company’s stock, valued at approximately $142,140. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Jaime Hill acquired 1,500 shares of the stock in a transaction dated Tuesday, August 11th. The stock was bought at an average cost of $47.12 per share, with a total value of $70,680.00. Following the completion of the purchase, the insider owned 29,698 shares of the company’s stock, valued at approximately $1,399,369.76. The trade was a 5.32% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 14,828 shares of company stock worth $697,479 over the last ninety days. Insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Institutional investors have recently bought and sold shares of the stock. XML Financial LLC lifted its stake in Amrize by 34.6% during the 2nd quarter. XML Financial LLC now owns 13,309 shares of the company’s stock valued at $709,000 after acquiring an additional 3,420 shares in the last quarter. Kerrisdale Advisers LLC grew its position in Amrize by 4.9% in the 2nd quarter. Kerrisdale Advisers LLC now owns 64,720 shares of the company’s stock worth $3,450,000 after purchasing an additional 3,000 shares in the last quarter. Ancora Advisors LLC increased its stake in Amrize by 22.9% in the 2nd quarter. Ancora Advisors LLC now owns 283,522 shares of the company’s stock valued at $15,112,000 after buying an additional 52,759 shares during the last quarter. Great Lakes Advisors LLC purchased a new stake in Amrize in the 2nd quarter valued at about $16,975,000. Finally, HF Advisory Group LLC lifted its position in shares of Amrize by 323.3% during the 2nd quarter. HF Advisory Group LLC now owns 21,325 shares of the company’s stock worth $1,137,000 after buying an additional 16,287 shares in the last quarter.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.